Department of Obstetrics and Gynaecology

Association of prenatal alcohol exposure and prenatal depressive symptoms with offspring hair cortisol in childhood and adolescence (2025) Plank AC, Panaseth-Gehle K, Gerlach J, Mestermann S, Fasching P, Beckmann M, Kratz O, et al. Journal article Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy (2025) Pfister K, Friedl TW, Hartkopf A, Mergel F, Huesmann S, Mehmeti F, Schäffler H, et al. Journal article Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 (2025) Reimer T, Kuehn T, Mueller V, Ditsch N, Fehm T, Albert US, Bartsch R, et al. Journal article, Review article Cross-sectional study on user requirements for developing a digital patient navigator app (2025) Seitz K, Langbein M, Goossens C, Altmannshofer S, Fasching P, Hack C, Heindl F, et al. Journal article Virtual contrast-enhanced maximum intensity projections from high-b-value diffusion-weighted breast MRI: a feasibility study (2025) Liebert A, Schreiter H, Hadler D, Kapsner L, Ohlmeyer S, Eberle J, Erber R, et al. Journal article Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial (2025) Fasching P, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, et al. Journal article Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment (2025) Pelzl R, Benintende G, Gsottberger F, Scholz JK, Rübner M, Yao H, Wendland K, et al. Journal article Assessing the catchment area of German comprehensive cancer centers by merging geographic healthcare data - an initiative of the ONCOnnect consortium (2025) Kerscher A, Metzler M, Kapitza J, Bernhardt L, Dedner K, Krebs M, Brandts CH Journal article Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article